Lipopolysaccharide-induced HIV-1 expression in transgenic mice is mediated by tumor necrosis factor-α and interleukin-1, but not by interferon-γ nor interleukin-6
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
Effect of cytokines on HIV-induced depletion of thymocytes in vivo
Neurocognitive and psychological contributions to quality of life in HIV-1-infected women
Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study
Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection
A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001)
Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients
Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine
Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients
Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study
High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples
Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania
Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires
Quality of life assessment comes of age in the era of highly active antiretroviral therapy
Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use
Increased β-chemokine production in peripheral blood mononuclear cells derived from HIV-1-infected individuals by a cationic amphiphilic drug (AY 9944) in vitro
Absence of an association between the presence of human herpesvirus 8 antibodies and the development of Kaposi's sarcoma in HIV-1-infected patients receiving antiretroviral therapy
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection
Antiretroviral resistance testing policy in England's north Thames HIV units: a survey of current practice
Increased serum levels of CD44s and CD44v6 in patients with AIDS-related non-Hodgkin's lymphoma
Changes in HIV/AIDS prevention indicators in the rural district of Lira in Uganda
β3-Adrenergic receptor polymorphism and the antiretroviral therapy-related lipodystrophy syndrome
TT virus DNA in serum, peripheral blood mononuclear cells and semen of patients infected by HIV
Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing
HIV-1 testing in pregnancy: acceptability and correlates of return for test results
Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy
Primary infection with human herpesvirus 8 in an HIV-1-infected patient
HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations
A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age